Valuation: Cannabis Poland S.A.

Market Cap 15.17M 3.84M 3.45M 3.19M 2.88M 5.39M 366M 5.45M 38.09M 191M 14.41M 14.11M 608M P/E 2024
-8.17x
P/E 2025 -4.44x
Enterprise Value 13.98M 3.54M 3.18M 2.94M 2.66M 4.97M 337M 5.03M 35.1M 176M 13.28M 13M 560M EV / Sales 2024
53.4x
EV / Sales 2025 42.8x
Free-Float
93.03%
Yield 2024 *
-
Yield 2025 -
1 day-2.45%
1 week-8.72%
Current month-12.72%
1 month-7.87%
3 months+19.16%
6 months+6.42%
Current year+0.71%
1 week 0.2
Extreme 0.195
0.22
1 month 0.2
Extreme 0.195
0.25
Current year 0.14
Extreme 0.141
0.31
1 year 0.14
Extreme 0.141
0.31
3 years 0.14
Extreme 0.141
1.04
5 years 0.14
Extreme 0.141
2.13
10 years 0.14
Extreme 0.141
4.29
Manager TitleAgeSince
Corporate Officer/Principal 54 2019-09-01
Director TitleAgeSince
Director/Board Member - 2022-10-31
Director/Board Member 50 2016-12-31
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
-2.45%-8.72%-27.11%-49.81% 3.84M
+0.55%+1.38%+57.08%+127.72% 1,143B
+0.79%+4.93%+44.70%+83.96% 647B
+0.37%+0.90%+26.29%+102.52% 506B
-0.05%+1.73%+52.74%+65.27% 384B
-0.87%-6.09%+61.73%+37.08% 350B
+0.34%+1.84%+30.70%+52.69% 293B
-0.45%+1.19%+2.89%+24.92% 265B
+0.38%+2.61%+53.99%+70.90% 242B
+0.24%+3.79%+35.21%+104.94% 197B
Average -0.09%-0.39%+33.82%+62.02% 402.75B
Weighted average by Cap. +0.29%+0.71%+44.47%+86.93%

Financials

2024 2025
Net sales 250K 63.36K 56.85K 52.56K 47.6K 88.93K 6.03M 90.01K 628K 3.16M 238K 233K 10.02M 201K 50.89K 45.66K 42.21K 38.23K 71.43K 4.85M 72.29K 505K 2.54M 191K 187K 8.05M
Net income -2.04M -517K -464K -429K -389K -726K -49.29M -735K -5.13M -25.79M -1.94M -1.9M -81.87M -2.21M -558K -501K -463K -419K -784K -53.17M -793K -5.54M -27.82M -2.1M -2.05M -88.33M
Net Debt -3.33M -843K -756K -699K -633K -1.18M -80.26M -1.2M -8.36M -42M -3.16M -3.1M -133M -1.19M -301K -270K -250K -226K -423K -28.68M -428K -2.99M -15.01M -1.13M -1.11M -47.65M
Projected Income Statement - Annual - Cannabis Poland S.A.
Logo Cannabis Poland S.A.
Cannabis Poland SA, formerly Telehorse SA, is a Poland-based company engaged in the Pharmaceutical and Medicine Manufacturing activity. The Company focuses on operating in the field of production and sale of pharmaceutical and medical products, with the main focus on vaporization products containing cannabinoids manufactured from cannabis. The Company also expands its activity to include other products than pharmaceuticals, such as cosmetics, oils containing cannabinoids for human and animals and photovoltaic cells. The Company is engaged in research and development of a Cannabidiol (CBD)/ Tetrahydrocannabinol-based (THC-based) pharmaceutical for use in the treatment of seizures associated with drug-resistant epilepsy.
Employees
3
Date Price Change Volume
26-10-28 PLN 0.1990 -2.45% 115,331
26-10-27 PLN 0.2040 0.00% 155,440
26-10-26 PLN 0.2040 -4.67% 471,980
26-10-23 PLN 0.2140 -1.83% 174,283
26-10-22 PLN 0.2180 0.00% 288,448